Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 28, 2023		Oct. 29, 2022		Oct. 28, 2023		Oct. 29, 2022
Income Statement [Abstract]
Net sales	$ 579,315	[1]	$ 603,788	[2]	$ 1,585,674	[3]	$ 1,659,868	[4]
Cost of sales	300,890		309,981		828,921		860,303
Gross margin	278,425		293,807		756,753		799,565
Selling and administrative expenses	267,474		267,734		778,491		756,318
Goodwill impairment	0		0		28,453	[5]	0
Asset impairments and other, net	99	[6]	0		581	[7]	(154)	[8]
Operating income (loss)	10,852		26,073		(50,772)		43,401
Other components of net periodic benefit cost	148		50		388		198
Interest expense, net	2,207		906		6,241		1,608
Earnings (loss) from continuing operations before income taxes	8,497		25,117		(57,401)		41,595
Income tax expense (benefit)	1,908		4,693		(13,483)		8,551
Earnings (loss) from continuing operations	6,589		20,424		(43,918)		33,044
Loss from discontinued operations, net of tax	(50)		(48)		(98)		(78)
Net Earnings (Loss)	$ 6,539		$ 20,376		$ (44,016)		$ 32,966
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ 0.6		$ 1.68		$ (3.87)		$ 2.61
Discontinued operations (in dollars per share)	0		0		(0.01)		0
Net earnings (loss) (in dollars per share)	0.6		1.68		(3.88)		2.61
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	0.6		1.66		(3.87)		2.56
Discontinued operations (in dollars per share)	0		(0.01)		(0.01)		0
Net earnings (loss) (in dollars per share)	$ 0.6		$ 1.65		$ (3.88)		$ 2.56
Weighted average shares outstanding:
Basic (in shares)	10,898		12,138		11,353		12,637
Diluted (in shares)	10,972		12,326		11,353		12,901

[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

[3] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

[4] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

[5] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[7] (3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[8] (2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.